Treatment of neonatal jaundice;Behandling av gulsott hos nyfødte

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 5, 2005, Pages 594-598

  Hansen, Thor Willy Ruud ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN INJURY; DISEASE EXACERBATION; DISEASE SEVERITY; FOLLOW UP; HEMOLYSIS; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; KERNICTERUS; MEDICAL SOCIETY; NEWBORN; NEWBORN JAUNDICE; NORWAY; PEDIATRICIAN; PRACTICE GUIDELINE; PREMATURITY; RISK ASSESSMENT; RISK FACTOR; SAFETY;

BILIRUBIN; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; PHOTOTHERAPY; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 14844300083     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hansen TWR, Neonatal jaundice. I: Altschuler S et al, red. Pediatrics: an on-line medical reference. 1. utg. St. Petersburg: Emedicine Online Textbooks, Emedicine.com, 2001. (www.emedicine.com/ PED/topic1061.htm (2001).)
2. Hansen TWR. Recent advances in pharmacotherapy for hyperbilirubinaemia in the neonate. Exp Opion Pharmacother 2003; 4: 1939-48.
3. Hansen TWR. Therapeutic practices in neonatal jaundice: an international survey. Clin Pediatr 1996; 35: 309-16.
4. Hansen TWR. Behandling av ikterus hos nyfødte. Norske retningslinjer i internasjonalt perspektiv. Tidsskr Nor Lægeforen 1996; 116: 3215-8.
5. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89: 809-18.
6. American Academy of Pediatrics Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558-65.
7. Ebbesen F. Recurrence of kernicterus in term and near term infants in Denmark. Acta Paediatr 2000; 89: 1213-7.
8. Kernicterus in full-term infants - United States, 1994-1998. MMWR Morb Mortal Wkly Rep 2001; 50: 491-4.
9. Maisels MJ, Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 1998; 101: 995-8.
10. Seidman DS, Paz I, Armon Y et al. Effect of publication of the «Practice Parameter for the management of hyperbilirubinemia» on treatment of neonatal jaundice. Acta Paediatr 2001; 90: 292-5.
11. Hansen TWR. Guidelines for treatment of neonatal jaundice. Is there a place for evidence-based medicine? Acta Paediatr 2001; 90: 239-41.
12. Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 1998; 25: 555-74.
13. Bhutani VK, Karp KM, Sivieri EM et al. Report from pilot kernicterus registry: clinical characteristics in term and near-term infants discharged as healthy who develop kernicterus. Pediatr Res 2004; 55: 474A.
14. Hankø E, Lindemann R, Hansen TWR. Spectrum of outcome in infants with extreme neonatal jaundice. Acta Paediatr 2001; 90: 782-5.
15. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia, Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
16. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term infants. Pediatrics 1999; 103: 6-14.
17. Bhutani VK, Gourley GR, Adler S et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess risk of severe hyperbilirubinemia. Pediatrics 2000; 106: E17.
18. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396-403.
19. Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol 1998; 25: 575-90.
20. Newman TB, Xiong B, Gonzales VN et al. Prediction and prevention of extreme hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000; 154: 1140-7.
21. Christensen T, Amundsen I, Kinn G et al. Terapienheterog belysningsforhold ved lysbehandling av nyfødte med hyperbilirubinemi. SIS-rapport 1992: 2. Østerås: Statens institutt for strålehygiene, 1992.
22. Meslo M, Tveiten L, Hansen TWR. Effektivisering av lysbehandling med enkle midler. Jordmorbladet 2000; 7: 18-21.
23. Hansen TWR. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997; 86: 843-6.
24. Rübo J, Albrecht K, Lasch P et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia cause by Rh hemolytic disease. J Pediatr 1992; 121: 93-7.
25. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-10.
26. Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants. Lancet 1958; 1: 1094-7.